ATLASCaribou Biosciences (CRBU) earnings date: Nov 11, 2026
Caribou Biosciences (CRBU) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026, after the close. Analysts expect EPS of -$0.27.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CRBU
| Last price | $0.44 (+4.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±8.8% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Caribou Biosciences stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Caribou Biosciences reports on Nov 11, 2026. One email the day before, with ATLAS’s read on Caribou Biosciences. You can switch it off at any time.
Alert me before CRBU reportsFree to start. Creating an account takes under a minute.
Notify me when Caribou Biosciences reports
Track CRBU free Add Caribou Biosciences to a free ATLAS watchlist and see its next report date in one place.
CRBU earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.27 |
| Last report | Aug 13, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +41.1% |
| Average move around a report | ±5.7% (last 5) |
| Sector | Healthcare · Biotechnology |
Caribou Biosciences earnings history: last 5 reports
Caribou Biosciences last reported on Aug 13, 2026: EPS of -$0.24 against an estimate of -$0.31 (+22.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$0.31 | -$0.24 | +22.6% | Beat | -7.1% |
| Jul 24, 2026 | $1.55 | $1.68 | +8.4% | Beat | -2.5% |
| Jun 26, 2026 | -$0.12 | $0.05 | +141.7% | Beat | +12.7% |
| May 7, 2026 | -$0.31 | -$0.26 | +16.1% | Beat | -0.5% |
| Mar 20, 2026 | -$0.18 | -$0.15 | +16.7% | Beat | -5.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CRBU
See the fair value, the probability range and the earnings history of Caribou Biosciences on its ATLAS page.
Caribou Biosciences (CRBU) stock analysisPlans from €3.99 a month.
Caribou Biosciences earnings: frequently asked questions
When does Caribou Biosciences (CRBU) report earnings?
Caribou Biosciences is scheduled to report on Wednesday, November 11, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CRBU?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.27 per share (USD). Estimates can change before the report.
How often does CRBU beat earnings estimates?
Of its last 5 reports with a recorded result, Caribou Biosciences beat the EPS estimate 5 times; the average surprise was +41.1%. Past results do not predict the next one.
How much does CRBU move around earnings?
Over its last 5 reports the stock moved an average of 5.7% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Caribou Biosciences beat earnings estimates last quarter?
Caribou Biosciences last reported on Aug 13, 2026: EPS of -$0.24 against an estimate of -$0.31 (+22.6% surprise), a beat.
How much does CRBU usually move in a day?
On a normal trading day the ATLAS model puts CRBU’s one-day range at about ±8.8%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer